These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35408914)

  • 61. Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate.
    Migdalska-Richards A; Ko WKD; Li Q; Bezard E; Schapira AHV
    Synapse; 2017 Jul; 71(7):. PubMed ID: 28295625
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Individualized screening for chaperone activity in Gaucher disease using multiple patient derived primary cell lines.
    Ivanova MM; Changsila E; Turgut A; Goker-Alpan O
    Am J Transl Res; 2018; 10(11):3750-3761. PubMed ID: 30662625
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Human Acid β-Glucosidase Inhibition by Carbohydrate Derived Iminosugars: Towards New Pharmacological Chaperones for Gaucher Disease.
    Parmeggiani C; Catarzi S; Matassini C; D'Adamio G; Morrone A; Goti A; Paoli P; Cardona F
    Chembiochem; 2015 Sep; 16(14):2054-64. PubMed ID: 26376302
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Commentary on "Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease" by Zimran et al.
    Goker-Alpan O
    Blood Cells Mol Dis; 2013 Feb; 50(2):138-9. PubMed ID: 23083682
    [No Abstract]   [Full Text] [Related]  

  • 65. Analyses of catalytic activity and inhibitor binding of human acid beta-glucosidase by site-directed mutagenesis. Identification of residues critical to catalysis and evidence for causality of two Ashkenazi Jewish Gaucher disease type 1 mutations.
    Grace ME; Graves PN; Smith FI; Grabowski GA
    J Biol Chem; 1990 Apr; 265(12):6827-35. PubMed ID: 2324100
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones.
    Yang C; Rahimpour S; Lu J; Pacak K; Ikejiri B; Brady RO; Zhuang Z
    Proc Natl Acad Sci U S A; 2013 Jan; 110(3):966-71. PubMed ID: 23277556
    [TBL] [Abstract][Full Text] [Related]  

  • 67. X-ray and biochemical analysis of N370S mutant human acid β-glucosidase.
    Wei RR; Hughes H; Boucher S; Bird JJ; Guziewicz N; Van Patten SM; Qiu H; Pan CQ; Edmunds T
    J Biol Chem; 2011 Jan; 286(1):299-308. PubMed ID: 20980263
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Docking study and biological evaluation of pyrrolidine-based iminosugars as pharmacological chaperones for Gaucher disease.
    Kato A; Nakagome I; Sato K; Yamamoto A; Adachi I; Nash RJ; Fleet GW; Natori Y; Watanabe Y; Imahori T; Yoshimura Y; Takahata H; Hirono S
    Org Biomol Chem; 2016 Jan; 14(3):1039-48. PubMed ID: 26633162
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Promising Effect of High Dose Ambroxol Treatment on Neurocognition and Motor Development in a Patient With Neuropathic Gaucher Disease 2.
    Aries C; Lohmöller B; Tiede S; Täuber K; Hartmann G; Rudolph C; Muschol N
    Front Neurol; 2022; 13():907317. PubMed ID: 35734474
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Targeted delivery of pharmacological chaperones for Gaucher disease to macrophages by a mannosylated cyclodextrin carrier.
    Rodríguez-Lavado J; de la Mata M; Jiménez-Blanco JL; García-Moreno MI; Benito JM; Díaz-Quintana A; Sánchez-Alcázar JA; Higaki K; Nanba E; Ohno K; Suzuki Y; Ortiz Mellet C; García Fernández JM
    Org Biomol Chem; 2014 Apr; 12(14):2289-301. PubMed ID: 24589885
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ambroxol as Therapy for Gaucher Disease-Ambitious but Ambivalent.
    Weinreb NJ; Goker-Alpan O
    JAMA Netw Open; 2023 Jun; 6(6):e2319336. PubMed ID: 37342045
    [No Abstract]   [Full Text] [Related]  

  • 72. The pharmacological chaperone effect of N-octyl-beta-valienamine on human mutant acid beta-glucosidases.
    Luan Z; Li L; Ninomiya H; Ohno K; Ogawa S; Kubo T; Iida M; Suzuki Y
    Blood Cells Mol Dis; 2010 Jan; 44(1):48-54. PubMed ID: 19857976
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of the non-lysosomal glucosylceramidase as beta-glucosidase 2.
    Boot RG; Verhoek M; Donker-Koopman W; Strijland A; van Marle J; Overkleeft HS; Wennekes T; Aerts JM
    J Biol Chem; 2007 Jan; 282(2):1305-12. PubMed ID: 17105727
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glucocerebrosidase inhibitors for the treatment of Gaucher disease.
    Trapero A; Llebaria A
    Future Med Chem; 2013 Apr; 5(5):573-90. PubMed ID: 23573974
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Analysis of human acid beta-glucosidase by site-directed mutagenesis and heterologous expression.
    Grace ME; Newman KM; Scheinker V; Berg-Fussman A; Grabowski GA
    J Biol Chem; 1994 Jan; 269(3):2283-91. PubMed ID: 8294487
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease.
    Jung O; Patnaik S; Marugan J; Sidransky E; Westbroek W
    Expert Rev Proteomics; 2016 May; 13(5):471-9. PubMed ID: 27098312
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Glucosylceramide mimics: highly potent GCase inhibitors and selective pharmacological chaperones for mutations associated with types 1 and 2 Gaucher disease.
    Schönemann W; Gallienne E; Ikeda-Obatake K; Asano N; Nakagawa S; Kato A; Adachi I; Górecki M; Frelek J; Martin OR
    ChemMedChem; 2013 Nov; 8(11):1805-17. PubMed ID: 24115322
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Beta-glucosidase 1 (GBA1) is a second bile acid β-glucosidase in addition to β-glucosidase 2 (GBA2). Study in β-glucosidase deficient mice and humans.
    Harzer K; Blech-Hermoni Y; Goldin E; Felderhoff-Mueser U; Igney C; Sidransky E; Yildiz Y
    Biochem Biophys Res Commun; 2012 Jun; 423(2):308-12. PubMed ID: 22659419
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Turnover and distribution of intravenously administered mannose-terminated human acid beta-glucosidase in murine and human tissues.
    Xu YH; Ponce E; Sun Y; Leonova T; Bove K; Witte D; Grabowski GA
    Pediatr Res; 1996 Feb; 39(2):313-22. PubMed ID: 8825806
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The management of cystic fibrosis with carbocysteine lysine salt: single-blind comparative study with ambroxol hydrochloride.
    Caramia G; Gagliardini R; Ruffini E; Osimani P; Nobilini A
    J Int Med Res; 1995; 23(4):284-93. PubMed ID: 7589772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.